UNSPSC 85522215: Supplement left face vein with autologous tissue substitute, open approach

This classification denotes the group of activities that yields a surgical intervention or procedure to supplement left face vein with autologous tissue substitute, open approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 05UV07Z

UNSPSC 85522215 Supplement left face vein with autologous tissue substitute, open approach is a Commodity code that nominally describes a surgical vascular procedure, but the recent state and local opportunities posted under this code show no alignment with vascular or surgical services. Instead, the solicitations tagged to this code span prison healthcare management, pharmacy benefit management, virtual primary and urgent care services, peer support for behavioral health workers, and fire department medical direction — none of which involve the vascular surgical intervention the code nominally names. The mismatch suggests either a data classification error in the source or systematic miscoding at the issuing bodies. As a result, this code shows no relevant recent activity for vendors pursuing work in vascular surgery or related surgical specialties through state and local procurement channels.

The five posted opportunities span correctional healthcare (Columbus Consolidated Government, Muscogee County Prison, Georgia), county pharmacy and medical benefit administration (Collier County, Florida and Monroe County, Florida), mental health peer support (San Mateo County, California), and fire department medical direction (Santa Monica, California). Geographic activity centers on Florida and Georgia, with secondary activity in California. The Muscogee County Prison medical and pharmacy services RFP (due May 15, 2026) budgets approximately $95,537.71 monthly for an existing contract; Collier County's pharmacy benefit management solicitation notes historical spend of approximately $8.7 million annually and was due April 9, 2026. None of these opportunities map to the code's stated scope.